These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 22136543)

  • 21. Adverse drug reactions in hospital and ambulatory care settings identified using a large administrative database.
    Kane-Gill SL; Van Den Bos J; Handler SM
    Ann Pharmacother; 2010 Jun; 44(6):983-93. PubMed ID: 20442350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse drug reactions in utero: perspectives on teratogens and strategies for the future.
    Mitchell AA
    Clin Pharmacol Ther; 2011 Jun; 89(6):781-3. PubMed ID: 21593753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cascade iatrogenesis: factors leading to the development of adverse events in hospitalized older adults.
    Thornlow DK; Anderson R; Oddone E
    Int J Nurs Stud; 2009 Nov; 46(11):1528-35. PubMed ID: 19643409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece.
    Alexopoulou A; Dourakis SP; Mantzoukis D; Pitsariotis T; Kandyli A; Deutsch M; Archimandritis AJ
    Eur J Intern Med; 2008 Nov; 19(7):505-10. PubMed ID: 19013378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Preventable or unavoidable? A new stage in the topic of drug safety].
    Otero MJ; Bajo A; García-Gutiérrez JF; Domínquez-Gil A
    Med Clin (Barc); 1999 Mar; 112(10):398-9. PubMed ID: 10227024
    [No Abstract]   [Full Text] [Related]  

  • 26. National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents.
    Cohen AL; Budnitz DS; Weidenbach KN; Jernigan DB; Schroeder TJ; Shehab N; Pollock DA
    J Pediatr; 2008 Mar; 152(3):416-21. PubMed ID: 18280852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization.
    von Euler M; Eliasson E; Ohlén G; Bergman U
    Pharmacoepidemiol Drug Saf; 2006 Mar; 15(3):179-84. PubMed ID: 16184621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Preventable adverse drug effects at an emergency department].
    Otero López MJ; Bajo Bajo A; Maderuelo Fernández JA; Domínguez-Gil Hurlé A
    Rev Clin Esp; 1999 Dec; 199(12):796-805. PubMed ID: 10687412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experience with a trigger tool for identifying adverse drug events among older adults in ambulatory primary care.
    Singh R; McLean-Plunckett EA; Kee R; Wisniewski A; Cadzow R; Okazaki S; Fox C; Singh G
    Qual Saf Health Care; 2009 Jun; 18(3):199-204. PubMed ID: 19468002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The current state of treatment of adverse reactions to injectable fillers.
    Sperling B; Bachmann F; Hartmann V; Erdmann R; Wiest L; Rzany B
    Dermatol Surg; 2010 Nov; 36 Suppl 3():1895-904. PubMed ID: 20969667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse drug reactions in hospitalized psychiatric patients.
    Thomas M; Boggs AA; DiPaula B; Siddiqi S
    Ann Pharmacother; 2010 May; 44(5):819-25. PubMed ID: 20371749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postmarketing surveillance of serious adverse events associated with the use of rofecoxib from 1999-2002.
    Bottone FG; Barry WT
    Curr Med Res Opin; 2009 Jun; 25(6):1535-50. PubMed ID: 19453292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multidisciplinary approach to adverse drug events in pediatric trauma patients in an adult trauma center.
    Kalina M; Tinkoff G; Gleason W; Veneri P; Fulda G
    Pediatr Emerg Care; 2009 Jul; 25(7):444-6. PubMed ID: 19564808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustaining and spreading the reduction of adverse drug events in a multicenter collaborative.
    Tham E; Calmes HM; Poppy A; Eliades AB; Schlafly SM; Namtu KC; Smith DM; Vitaska MC; McConnell C; Potts AL; Jastrzembski J; Logsdon TR; Hall M; Takata GS
    Pediatrics; 2011 Aug; 128(2):e438-45. PubMed ID: 21727100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse drug reactions and drug interactions as causes of hospital admission in oncology.
    Miranda V; Fede A; Nobuo M; Ayres V; Giglio A; Miranda M; Riechelmann RP
    J Pain Symptom Manage; 2011 Sep; 42(3):342-53. PubMed ID: 21454043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse drug reactions as the cause of emergency department admission: focus on the elderly.
    Ventura MT; Laddaga R; Cavallera P; Pugliese P; Tummolo RA; Buquicchio R; Pierucci P; Passalacqua G
    Immunopharmacol Immunotoxicol; 2010 Sep; 32(3):426-9. PubMed ID: 20095805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization and classification of adverse drug interactions.
    Takarabe M; Shigemizu D; Kotera M; Goto S; Kanehisa M
    Genome Inform; 2010 Jan; 22():167-75. PubMed ID: 20238427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse drug events associated with yohimbine-containing products: a retrospective review of the California Poison Control System reported cases.
    Kearney T; Tu N; Haller C
    Ann Pharmacother; 2010 Jun; 44(6):1022-9. PubMed ID: 20442348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of cerebrovascular adverse events in older adults using antipsychotic agents: a propensity-matched retrospective cohort study.
    Mehta S; Johnson ML; Chen H; Aparasu RR
    J Clin Psychiatry; 2010 Jun; 71(6):689-98. PubMed ID: 20573328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of acute adverse reactions to gadobutrol--a highly concentrated macrocyclic gadolinium chelate: review of 14,299 patients from observational trials.
    Forsting M; Palkowitsch P
    Eur J Radiol; 2010 Jun; 74(3):e186-92. PubMed ID: 19574008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.